Cardiac arrest & resuscitation
Improving vasopressor use in cardiac arrest
Study context
- Population
- Patients in cardiac arrest
- Comparison
- Vasopressors and drug administration routes in cardiac arrest
- Outcome
- Effect of vasopressors in cardiac arrest (ROSC, 30-day survival, survival with favourable neurological outcome)
Main finding
As reported in the abstract
- Adrenaline (1 mg) highly effective at achieving ROSC (NNT 4)
- Adrenaline less effective on survival to 30 days (NNT 111)
- Uncertain effects of adrenaline on survival with a favourable neurological outcome
- Vasopressin (alternative to or in addition to adrenaline) and high-dose adrenaline: no evidence of improved long-term outcomes in RCTs
- Narrative review
Original publication
Improving vasopressor use in cardiac arrest. Crit Care. Published 2 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →